我国otc市场今年将是医药渠道变革年（Chinas OTC market this year will be the year of pharmaceutical channels change）.docVIP

我国otc市场今年将是医药渠道变革年（Chinas OTC market this year will be the year of pharmaceutical channels change） This scenario pharmacies believe we are not unfamiliar: substantial promotional advertising, often marked 4 yuan Jiang Zhong Jianweixiaoshi, 2 yuan golden throat, 6 yuan quike capsule...... However, these 1/3 times cheaper than the market price of these commonly used drugs during the promotion period is two boxes per person.. A little later, the clerk will tell you, its sold out.. Careful consumers may also find that when they do not promote the purchase of these familiar drugs, but can only go to the bottom of the shelf to find, and even often out of stock. These best-selling for many years, the popularity of the advertising, and has a very well-known OTC drugs, the industry used to call it brand medicine.. In some retail pharmacies, brand medicines are often used to collect customers and sell negative gross profit sales. High margin products often by imitating the brand drug packaging, occupy the counter, increase the rebate measures such as terminal intercept of brand medicine. In many cases, more than one reporter heard this question: six packs a box of Xiaochaihu granules, how to have a price lower than the cost price! The prices of consumer and brand confusion, and Cuanhuo arbitrary price and other chronic illness has been accompanied by the OTC market. Sekishige years OTC distribution channels as blockage of the river flow, flood, settling down not profits, but the financial risk. An industry engaged in OTC marketing for so many years, so commented. The chaos in the OTC field has been almost choking on upstream industrial and commercial channels, while downstream pharmacies are mired in a conflict between the pursuit of goodwill or the retention of profits. Channel dredging One second to sell 8 boxes, world brand laboratory to the river brand valuation is 3 billion 700 million yuan. This is the general manager of Jiang pharmaceutical company Liu Hui said in the